Wei Liu and Lijuan Zhang contributed equally to this work.
Differential expression of STAT1 and IFN-γ in primary and invasive or metastatic wilms tumors
Article first published online: 21 JUN 2013
Copyright © 2013 Wiley Periodicals, Inc.
Journal of Surgical Oncology
Volume 108, Issue 3, pages 152–156, September 1, 2013
How to Cite
Liu, W., Zhang, L. and Wu, R. (2013), Differential expression of STAT1 and IFN-γ in primary and invasive or metastatic wilms tumors. J. Surg. Oncol., 108: 152–156. doi: 10.1002/jso.23364
- Issue published online: 27 JUL 2013
- Article first published online: 21 JUN 2013
- Manuscript Accepted: 28 MAY 2013
- Manuscript Received: 13 APR 2013
- Natural Science Foundation of Shandong Province in China. Grant Number: ZR2012HQ012
- Wilms tumor;
Background and Objectives
IFN/STAT1 signaling has been found to be not only associated with an aggressive tumor phenotype but also activated and functional during metanephric development. This study was undertaken to evaluate STAT1 and IFN-γ expression and its relation to histopathological features of primary and invasive/metastatic Wilms tumors.
Immunohistochemistry was used to determine the expression and cellular distribution of STAT1 and IFN-γ in 18 pairs of primary and corresponding invasive/metastatic Wilms tumors and 40 primary tumors without invasion or metastasis.
Positive rate of STAT1/IFN-γ expression was 66.7%/61.1% and 72.2%/77.8% in 18 pairs of primary and associated invasive/metastatic Wilms tumor tissues, while 35.0%/27.5% in 40 primary tumors without invasion or metastasis. The expression of STAT1 and IFN-γ was significantly associated with invasion/metastasis (P = 0.025; P = 0.015). There was a positive correlation between STAT1 and IFN-γ expression in all Wilms tumor tissues (χ2 = 23.408, P = 0.05, r = 0.555). The expression of STAT1 and IFN-γ between primary and matched invasive/metastatic tissues was concordance, respectively (P = 0.710 and P = 0.375).
These results suggest that IFN-γ/STAT1 signaling might have clinical potential as a promising predictor to identify individuals with poor prognostic potential and as a possible novel target molecule of therapy for Wilms tumor. J. Surg. Oncol. 2013; 108:152–156. © 2013 Wiley Periodicals, Inc.